These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 39161777)

  • 1. Molecular dynamic simulation reveals the inhibiting impact of Rhein on wild-type and P29S-mutated Rac1.
    Etebar N; Hamidi SH; Naderpour S; Abouali O; Hamidi SH; Hajipour-Verdom B; Zali A; Alipour M; Rahimzadegan M
    Front Mol Biosci; 2024; 11():1414197. PubMed ID: 39161777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Differences of Activation of Rac1
    Senyuz S; Jang H; Nussinov R; Keskin O; Gursoy A
    J Phys Chem B; 2021 Apr; 125(15):3790-3802. PubMed ID: 33848152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of point mutation P29S in RAC1 on tumorigenesis.
    Rajendran V; Gopalakrishnan C; Purohit R
    Tumour Biol; 2016 Nov; 37(11):15293-15304. PubMed ID: 27699663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOCK1 inhibition suppresses cancer cell invasion and macropinocytosis induced by self-activating Rac1
    Tomino T; Tajiri H; Tatsuguchi T; Shirai T; Oisaki K; Matsunaga S; Sanematsu F; Sakata D; Yoshizumi T; Maehara Y; Kanai M; Cote JF; Fukui Y; Uruno T
    Biochem Biophys Res Commun; 2018 Feb; 497(1):298-304. PubMed ID: 29432733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAC1P29S is a spontaneously activating cancer-associated GTPase.
    Davis MJ; Ha BH; Holman EC; Halaban R; Schlessinger J; Boggon TJ
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):912-7. PubMed ID: 23284172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAC1mutation is not a predictive biomarker for PI3'-kinase-β-selective pathway-targeted therapy.
    Foth M; Parkman G; Battistone B; McMahon M
    Pigment Cell Melanoma Res; 2020 Sep; 33(5):719-730. PubMed ID: 32406574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhein Derivative 4F Inhibits the Malignant Phenotype of Breast Cancer by Downregulating Rac1 Protein.
    Li X; Liu Y; Zhao Y; Tian W; Zhai L; Pang H; Kang J; Hou H; Chen Y; Li D
    Front Pharmacol; 2020; 11():754. PubMed ID: 32547389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAC1
    Lionarons DA; Hancock DC; Rana S; East P; Moore C; Murillo MM; Carvalho J; Spencer-Dene B; Herbert E; Stamp G; Damry D; Calado DP; Rosewell I; Fritsch R; Neubig RR; Molina-Arcas M; Downward J
    Cancer Cell; 2019 Jul; 36(1):68-83.e9. PubMed ID: 31257073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique vulnerability of
    Cannon AC; Budagyan K; Uribe-Alvarez C; Kurimchak AM; Araiza-Olivera D; Cai KQ; Peri S; Zhou Y; Duncan JS; Chernoff J
    bioRxiv; 2023 Jun; ():. PubMed ID: 37425776
    [No Abstract]   [Full Text] [Related]  

  • 10. Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells.
    Zhou G; Peng F; Zhong Y; Chen Y; Tang M; Li D
    Int J Oncol; 2017 Mar; 50(3):933-941. PubMed ID: 28098862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints.
    Cannon AC; Budagyan K; Uribe-Alvarez C; Kurimchak AM; Araiza-Olivera D; Cai KQ; Peri S; Zhou Y; Duncan JS; Chernoff J
    Oncogene; 2024 Mar; 43(10):729-743. PubMed ID: 38243078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Dendritic Actin Network Formation in Extended Lamellipodia Drives Proliferation in Growth-Challenged Rac1
    Mohan AS; Dean KM; Isogai T; Kasitinon SY; Murali VS; Roudot P; Groisman A; Reed DK; Welf ES; Han SJ; Noh J; Danuser G
    Dev Cell; 2019 May; 49(3):444-460.e9. PubMed ID: 31063759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic mutations on Rac1 affect global intrinsic dynamics underlying GTP and PAK1 binding.
    Acuner SE; Sumbul F; Torun H; Haliloglu T
    Biophys J; 2021 Mar; 120(5):866-876. PubMed ID: 33515600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhein Inhibited Ferroptosis and EMT to Attenuate Diabetic Nephropathy by Regulating the Rac1/NOX1/β-Catenin Axis.
    Xiong D; Hu W; Han X; Cai Y
    Front Biosci (Landmark Ed); 2023 May; 28(5):100. PubMed ID: 37258467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF.
    Watson IR; Li L; Cabeceiras PK; Mahdavi M; Gutschner T; Genovese G; Wang G; Fang Z; Tepper JM; Stemke-Hale K; Tsai KY; Davies MA; Mills GB; Chin L
    Cancer Res; 2014 Sep; 74(17):4845-4852. PubMed ID: 25056119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells.
    Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM
    J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamic simulation reveals damaging impact of RAC1 F28L mutation in the switch I region.
    Kumar A; Rajendran V; Sethumadhavan R; Purohit R
    PLoS One; 2013; 8(10):e77453. PubMed ID: 24146998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming mutations of RAC guanosine triphosphatases in human cancers.
    Kawazu M; Ueno T; Kontani K; Ogita Y; Ando M; Fukumura K; Yamato A; Soda M; Takeuchi K; Miki Y; Yamaguchi H; Yasuda T; Naoe T; Yamashita Y; Katada T; Choi YL; Mano H
    Proc Natl Acad Sci U S A; 2013 Feb; 110(8):3029-34. PubMed ID: 23382236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potent and novel inhibitors against RAC1: a Rho family GTPase.
    Madhukar G; Subbarao N
    In Silico Pharmacol; 2022; 10(1):13. PubMed ID: 35928028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAC1 P29S regulates PD-L1 expression in melanoma.
    Vu HL; Rosenbaum S; Purwin TJ; Davies MA; Aplin AE
    Pigment Cell Melanoma Res; 2015 Sep; 28(5):590-8. PubMed ID: 26176707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.